Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.950
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $131.09 million as of December 20, 2024. Its market cap has increased by 82.85% in one year.
Market Cap
131.09M
Enterprise Value
-86.78M
1-Year Change
82.85%
Ranking
Category
Stock Price
1.95
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $131.09M, a decrease of -67.49%. That is a compound annual growth rate of -28.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 131.09M | 76.08% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 140.42M |
| Nevro | 140.14M |
| Actuate Therapeutics | 139.07M |
| Telomir Pharmaceuticals | 138.28M |
| Achieve Life Sciences | 137.56M |
| Puma Biotechnology | 135.97M |
| Compugen | 135.20M |
| Seer, Inc. | 133.85M |